Sun Pharma Faces Nine-Year Wait After US Zubsolv Ruling
Indian Firm Fails To Find A Way Around A Pair Of US Patents
Executive Summary
Another ANDA sponsor has tried and failed to navigate Orexo’s patents for its opioid dependence sublingual tablets, Zubsolv.